Literature DB >> 6127805

Protection against experimental pyelonephritis by antibodies to pili.

F J Silverblatt, R Weinstein, P Rene.   

Abstract

Bacterial pili have been shown to be an important virulence factor for urinary tract infections. In this report we relate the results of studies which evaluated the influence of antipili antibody on the susceptibility of rats to ascending pyelonephritis and on several antibody-mediated antibacterial mechanisms. Rats immunized with E. coli type 1 pili, and animals infected with E. coli developed antipili antibodies in their serum. Active or passive immunization of rats with pili protected the animals from ascending pyelonephritis. Antipili antibody did not mediate complement-dependent bacteriolysis, opsonophagocytosis or promote more rapid intravascular clearance of injected E. coli. Humoral immunity to pili did, however, effectively inhibit bacterial adherence to epithelial cells. These studies indicate that type 1 E. coli pili are immunogenic and that antipili antibodies afford protection from ascending pyelonephritis. They suggest further that a mechanism of protection is inhibition of bacterial adherence.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127805

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  7 in total

1.  Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.

Authors:  K Thankavel; B Madison; T Ikeda; R Malaviya; A H Shah; P M Arumugam; S N Abraham
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Urinary antibody response after immunisation with a vaccine against urinary tract infection.

Authors:  D Kruze; K Holzbecher; M Andrial; W Bossart
Journal:  Urol Res       Date:  1989

Review 3.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors.

Authors:  S N Abraham; J P Babu; C S Giampapa; D L Hasty; W A Simpson; E H Beachey
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

5.  Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells.

Authors:  N Firon; S Ashkenazi; D Mirelman; I Ofek; N Sharon
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

6.  Modulation of Actinomyces viscosus colonization of mouse teeth in vivo by immunization with fimbrial adhesins.

Authors:  P C Crawford; W B Clark
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

7.  Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli.

Authors:  S N Abraham; D L Hasty; W A Simpson; E H Beachey
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.